Naureen Quibria
Stock Analyst at Capital One
(n/a)
# 4,673
Out of 5,090 analysts
8
Total ratings
11.11%
Success rate
-44.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Naureen Quibria
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMEA Biomea Fusion | Initiates: Overweight | $25 | $1.22 | +1,949.18% | 1 | Aug 29, 2024 | |
| IMMP Immutep | Initiates: Overweight | $10 | $1.80 | +455.56% | 1 | May 17, 2024 | |
| ERAS Erasca | Initiates: Overweight | $8 | $3.27 | +144.65% | 1 | Mar 11, 2024 | |
| IMCR Immunocore Holdings | Initiates: Overweight | $84 | $38.78 | +116.61% | 1 | Aug 16, 2023 | |
| DAWN Day One Biopharmaceuticals | Initiates: Overweight | $40 | $7.92 | +405.05% | 1 | Feb 8, 2023 | |
| FENC Fennec Pharmaceuticals | Initiates: Overweight | $11 | $7.55 | +45.70% | 1 | Sep 7, 2022 | |
| GNTA Genenta Science | Initiates: Buy | $21 | $1.87 | +1,022.99% | 1 | Jan 13, 2022 | |
| KZIA Kazia Therapeutics | Initiates: Buy | $900 | $15.05 | +5,880.07% | 1 | Oct 14, 2021 |
Biomea Fusion
Aug 29, 2024
Initiates: Overweight
Price Target: $25
Current: $1.22
Upside: +1,949.18%
Immutep
May 17, 2024
Initiates: Overweight
Price Target: $10
Current: $1.80
Upside: +455.56%
Erasca
Mar 11, 2024
Initiates: Overweight
Price Target: $8
Current: $3.27
Upside: +144.65%
Immunocore Holdings
Aug 16, 2023
Initiates: Overweight
Price Target: $84
Current: $38.78
Upside: +116.61%
Day One Biopharmaceuticals
Feb 8, 2023
Initiates: Overweight
Price Target: $40
Current: $7.92
Upside: +405.05%
Fennec Pharmaceuticals
Sep 7, 2022
Initiates: Overweight
Price Target: $11
Current: $7.55
Upside: +45.70%
Genenta Science
Jan 13, 2022
Initiates: Buy
Price Target: $21
Current: $1.87
Upside: +1,022.99%
Kazia Therapeutics
Oct 14, 2021
Initiates: Buy
Price Target: $900
Current: $15.05
Upside: +5,880.07%